Recent Publications
2023
Lu T, Shi X, Ge X, Li Y, Cai Y, Chen X, Hu S, Ding M, Fang X, Liu F, Zhou X, Wang X. Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma. Front Nutr. 2023 May 12;10:1080181. doi: 10.3389/fnut.2023.1080181. PMID: 37252237; PMCID: PMC10213411.
Zhang X, Han Y, Nie Y, Jiang Y, Sui X, Ge X, Liu F, Zhang Y, Wang X. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. J Mol Med (Berl). 2023 May;101(5):595-606. doi: 10.1007/s00109-023-02313-8. Epub 2023 May 1. PMID: 37126184.
Su P, Yan S, Yang J, Tong J, Samsom J, You F, Li Y, Chen Q, Jiang A, Zhai D, Chen J, Sun Z, Zhou J, Liu M, Lee FJS, Xu ZD, Wang X, Vasdev N, Wong AHC, Liu F. Serum amyloid P component (SAP) modulates antidepressant effects through promoting membrane insertion of the serotonin transporter. Neuropsychopharmacology. 2023 Feb;48(3):508-517. doi: 10.1038/s41386-022-01449-4. Epub 2022 Sep 8. PMID: 36076020; PMCID: PMC9852251.
2022
Su P, Zhai D, Wong AHC, Liu F. Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice. Mol Brain. 2022 Aug 9;15(1):71. doi: 10.1186/s13041-022-00956-1. PMID: 35945596; PMCID: PMC9361269.
Jiang A, Zhou C, Samsom J, Yan S, Yu DZ, Jia ZP, Wong AHC, Liu F. The GR-FKBP51 interaction modulates fear memory but not spatial or recognition memory. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Dec 20;119:110604. doi: 10.1016/j.pnpbp.2022.110604. Epub 2022 Jul 14. PMID: 35839967.
Tian Z, Liu M, Fang X, Zhou X, Li P, Li Y, Zhang L, Liu F, Zhang Y, Wang X. Distinct Age-Related Clinical Features and Risk Assessment in Chinese With Chronic Lymphocytic Leukemia. Front Oncol. 2022 May 12;12:885150. doi: 10.3389/fonc.2022.885150. PMID: 35646669; PMCID: PMC9135454.
Wang J, Su P, Yang J, Xu L, Yuan A, Li C, Zhang T, Dong F, Zhou J, Samsom J, Wong AHC, Liu F. The D2R-DISC1 protein complex and associated proteins are altered in schizophrenia and normalized with antipsychotic treatment. J Psychiatry Neurosci. 2022 Mar 31;47(2):E134-E147. doi: 10.1503/jpn.210145. PMID: 35361701; PMCID: PMC8979657.
Li Y, Su P, Chen Y, Nie J, Yuan TF, Wong AH, Liu F. The Eph receptor A4 plays a role in demyelination and depression-related behavior. J Clin Invest. 2022 Apr 15;132(8):e152187. doi: 10.1172/JCI152187. Erratum in: J Clin Invest. 2022 May 16;132(10): PMID: 35271507; PMCID: PMC9012277.
Yang J, Zhou J, Zhou J, Wang H, Sun Z, Zhu X, He Y, Wong AHC, Liu F, Wang G. Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder. J Psychiatr Res. 2022 Feb;146:172-178. doi: 10.1016/j.jpsychires.2021.12.051. Epub 2021 Dec 30. PMID: 34995992.
2021
Jiang A, Wang L, Lu JYD, Freeman A, Campbell C, Su P, Wong AHC, Liu F. Sex Differences in Dopamine Receptor Signaling in Fmr1 Knockout Mice: A Pilot Study. Brain Sci. 2021 Oct 24;11(11):1398. doi: 10.3390/brainsci11111398. PMID: 34827397; PMCID: PMC8615700.
Jiang A, Su P, Li S, Wong AHC, Liu F. Disrupting the α7nAChR-NR2A protein complex exerts antidepressant-like effects. Mol Brain. 2021 Jul 5;14(1):107. doi: 10.1186/s13041-021-00817-3. PMID: 34225758; PMCID: PMC8256601.
Lai TKY, Abela AR, Su P, Fletcher PJ, Liu F. Prenatal disruption of D1R-SynGAP complex causes cognitive deficits in adulthood. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110122. doi: 10.1016/j.pnpbp.2020.110122. Epub 2020 Oct 8. PMID: 33039433.
2020
Qin L, Tiwari AK, Zai CC, Freeman N, Zhai D, Liu F, Stachelscheid H, Mergenthaler P, Kennedy JL, Müller DJ. Regulation of melanocortin-4-receptor (MC4R) expression by SNP rs17066842 is dependent on glucose concentration. Eur Neuropsychopharmacol. 2020 Aug;37:39-48. doi: 10.1016/j.euroneuro.2020.05.008. Epub 2020 Jul 16. PMID: 32684494.
Su P, Zhang H, Wong AHC, Liu F. The DISC1 R264Q variant increases affinity for the dopamine D2 receptor and increases GSK3 activity. Mol Brain. 2020 Jun 3;13(1):87. doi: 10.1186/s13041-020-00625-1. PMID: 32493513; PMCID: PMC7271519.
Borroto-Escuela DO, Ferraro L, Narvaez M, Tanganelli S, Beggiato S, Liu F, Rivera A, Fuxe K. Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia. Cells. 2020 Apr 27;9(5):1077. doi: 10.3390/cells9051077. PMID: 32349279; PMCID: PMC7290895.
Li H, Su P, Lai TK, Jiang A, Liu J, Zhai D, Campbell CT, Lee FH, Yong W, Pasricha S, Li S, Wong AH, Ressler KJ, Liu F. The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder. J Clin Invest. 2020 Feb 3;130(2):877-889. doi: 10.1172/JCI130363. PMID: 31929189; PMCID: PMC6994126.
2019
Lai TKY, Zhai D, Su P, Jiang A, Boychuk J, Liu F. The receptor-receptor interaction between mGluR1 receptor and NMDA receptor: a potential therapeutic target for protection against ischemic stroke. FASEB J. 2019 Dec;33(12):14423-14439. doi: 10.1096/fj.201900417R. Epub 2019 Oct 31. PMID: 31670972.
Su P, Lai TKY, Lee FHF, Abela AR, Fletcher PJ, Liu F. Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration. Sci Signal. 2019 Aug 6;12(593):eaau9122. doi: 10.1126/scisignal.aau9122. PMID: 31387938.
Shah FA, Kury LA, Li T, Zeb A, Koh PO, Liu F, Zhou Q, Hussain I, Khan AU, Jiang Y, Li S. Polydatin Attenuates Neuronal Loss via Reducing Neuroinflammation and Oxidative Stress in Rat MCAO Models. Front Pharmacol. 2019 Jun 26;10:663. doi: 10.3389/fphar.2019.00663. PMID: 31293416; PMCID: PMC6606791.
Lee FHF, Lai TKY, Su P, Liu F. Altered cortical Cytoarchitecture in the Fmr1 knockout mouse. Mol Brain. 2019 Jun 14;12(1):56. doi: 10.1186/s13041-019-0478-8. PMID: 31200759; PMCID: PMC6570929.
Shah FA, Liu G, Al Kury LT, Zeb A, Abbas M, Li T, Yang X, Liu F, Jiang Y, Li S, Koh PO. Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways. Front Pharmacol. 2019 Mar 29;10:297. doi: 10.3389/fphar.2019.00297. Erratum in: Front Pharmacol. 2019 Jun 21;10:702. PMID: 31024297; PMCID: PMC6461025.
2018
Lai TKY, Su P, Zhang H, Liu F. Development of a peptide targeting dopamine transporter to improve ADHD-like deficits. Mol Brain. 2018 Nov 9;11(1):66. doi: 10.1186/s13041-018-0409-0. PMID: 30413217; PMCID: PMC6234781.
Liu J, Tong L, Song S, Niu Y, Li J, Wu X, Zhang J, Zai CC, Luo F, Wu J, Li H, Wong AHC, Sun R, Liu F, Li B. Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain. 2018 Sep 5;11(1):48. doi: 10.1186/s13041-018-0392-5. Erratum in: Mol Brain. 2018 Oct 16;11(1):59. PMID: 30185235; PMCID: PMC6125990.
Lee FHF, Zhang H, Jiang A, Zai CC, Liu F. Specific Alterations in Astrocyte Properties via the GluA2-GAPDH Complex Associated with Multiple Sclerosis. Sci Rep. 2018 Aug 27;8(1):12856. doi: 10.1038/s41598-018-31318-4. PMID: 30150703; PMCID: PMC6110783.
Chun LS, Vekariya RH, Free RB, Li Y, Lin DT, Su P, Liu F, Namkung Y, Laporte SA, Moritz AE, Aubé J, Frankowski KJ, Sibley DR. Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. Front Synaptic Neurosci. 2018 Feb 21;10:2. doi: 10.3389/fnsyn.2018.00002. PMID: 29515433; PMCID: PMC5826336.
Weïwer M, Xu Q, Gale JP, Lewis M, Campbell AJ, Schroeder FA, Van de Bittner GC, Walk M, Amaya A, Su P, D Ordevic L, Sacher JR, Skepner A, Fei D, Dennehy K, Nguyen S, Faloon PW, Perez J, Cottrell JR, Liu F, Palmer M, Pan JQ, Hooker JM, Zhang YL, Scolnick E, Wagner FF, Holson EB. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. ACS Chem Biol. 2018 Apr 20;13(4):1038-1047. doi: 10.1021/acschembio.8b00168. Epub 2018 Mar 14. PMID: 29485852.
For a more comprehensive list, please visit PubMed page.